Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
What type of medical monitoring is recommended
As with any supplement, individuals with medical conditions or those taking medications should consult a healthcare professional before use
Tirzepatide activeert de GIP- en GLP-1-receptoren
Figure 3a,b)
Always consult a healthcare provider if you are pregnant, breastfeeding, or have underlying medical conditions
Known side effects (class effects similar to other GLP-1 medications) Gastrointestinal issues (very common): Nausea: 38-43% of participants vs 11% placebo Diarrhea: 33-35% vs 13% placebo Vomiting: 20-21% vs 0% placebo Constipation: 22-25% vs 9% placebo Decreased appetite: 18-19% vs 9% placebo These are expected with incretin-based therapies and typically improve over time as your body adjusts
US$ 22.10
US$ 29.31
US$ 28.08
US$ 24.59
